| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Bain Capital Investors LLC | 10% Owner | 2026-04-20 | 8,398,438 | $16.00 | $134.38MBuy |
| Bain Capital Life Sciences Investors LLC | 10% Owner | 2026-04-20 | 1,562,500 | $16.00 | $25.00MBuy |
| Andrew T. Kaplan | Director | 2026-04-20 | 8,398,438 | $16.00 | $134.38MBuy |
| Adam Koppel | Director | 2026-04-20 | 1,562,500 | $16.00 | $25.00MBuy |
| Rtw Investments LP | 10% Owner | 2026-04-20 | 500,000 | $16.00 | $8.00MBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Andrew T. Kaplan | 20.26% | 26,255,581 | $508.57M | Insider |
| Bain Capital Investors LLC | 20.26% | 26,255,581 | $508.57M | Insider |
| Bain Capital Life Sciences Investors LLC | 17.43% | 22,583,268 | $437.44M | Insider |
| Adam Koppel | 17.43% | 22,583,268 | $437.44M | Insider |
| Rtw Investments LP | 8.32% | 10,776,820 | $208.75M | Insider |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 1.57% | 2,034,134 | $39.40M | Insider |